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Introduction
Fetal growth is an important indicator of 
child health because its impairment may 
be associated with poor neurodevelopment 
(Richards et al. 2002) and with chronic 
diseases in adulthood (Barker 2007). It 
has been hypothesized that some organo-
chlorine compounds (OCs) can cross the 
placenta (Vizcaino et al. 2014a) and may 
interfere with fetal development and growth 
(Windham and Fenster 2008).
To date, most studies on prenatal exposure 
to OCs and fetal growth have used anthro-
pometric measures at birth (El Majidi et al. 
2012; Govarts et al. 2012) and, to a lesser 
extent, outcomes such as being small for gesta-
tional age (Ribas-Fitó et al. 2002) as proxy 
measures of in utero growth. A limitation 
with these approaches is that fetal growth can 
be assessed only after delivery, and they do 
not allow different patterns of development 
to be examined throughout pregnancy. Thus, 
growth-retarded fetuses and healthy but 
constitutionally small ones may have the same 
birth weight (Gardosi 2004). In addition, it 
has been suggested that birth weight poorly 
reflects fetal growth during the first two 
trimesters of pregnancy (Gardosi 2004). 
Finally, assessment of birth size does not fully 
capture the time during gestation in which 
fetal growth failures begin or the onset of tran-
sient effects that may occur during intrauterine 
life. Therefore, the study of the effects of these 
contaminants on fetal growth using longitu-
dinal ultrasound measurements may be useful 
to identify specific prenatal periods of vulner-
ability to OC exposure, and especially the age 
at which fetal growth failure may begin.
Within the Spanish INMA (INfancia 
y  Medio Ambiente ;  Chi ldhood and 
Environment) Project, we aimed to examine 
the relationship between maternal and cord 
concentrations of 4,4´-dichlorodiphenyl-
dichloroethylene (4,4´-DDE), hexachloro-
benzene (HCB), and three polychlorinated 
biphenyls (PCBs) (congeners 138, 153, and 
180) and fetal growth using serial ultrasound 
measurements at 12, 20, and 34 weeks of 
pregnancy and taking into account the 
 individual growth potential of the fetus.
Material and Methods
Study design and population. The INMA 
Project is a multicenter population-based 
mother–child cohort study established in 
different areas of Spain following a common 
protocol (Guxens et al. 2012). This study 
included the cohorts of Asturias, Gipuzkoa, 
Sabadell, and Valencia. The hospital ethics 
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Background: Several studies have reported decreases in birth size associated with exposure to 
organochlorine compounds (OCs), but uncertainties remain regarding the critical windows of 
prenatal exposure and the effects on fetal body segments.
oBjective: We examined the relationship between prenatal OC concentrations and fetal 
anthropometry.
Methods: We measured 4,4´-dichlorodiphenyldichloroethylene (4,4´-DDE), hexachlorobenzene 
(HCB), and polychlorinated biphenyl (PCB) congeners (138, 153, and 180) in 2,369 maternal 
and 1,140 cord serum samples in four Spanish cohorts (2003–2008). We used linear mixed models 
to obtain longitudinal growth curves for estimated fetal weight (EFW), abdominal circumference 
(AC), biparietal diameter (BPD), and femur length (FL) adjusted by parental and fetal character-
istics. We calculated standard deviation (SD) scores of growth at 0–12, 12–20, and 20–34 weeks 
of gestation as well as size at gestational week 34 for the four parameters. We studied the asso-
ciation between OCs and the fetal outcomes by cohort-specific linear models and subsequent 
meta-analyses.
results: PCBs were associated with a reduction in AC up to mid-pregnancy, and BPD and 
FL from gestational week 20 onward. An inverse association was also found between HCB and 
AC growth in early pregnancy. The reduction of these parameters ranged from –4% to –2% 
for a doubling in the OC concentrations. No association between 4,4´-DDE and fetal growth 
was observed.
conclusions: To our knowledge, this is the first study to report an association between prenatal 
exposure to some PCBs and HCB and fetal growth: AC during the first two trimesters of preg-
nancy, and BPD and FL later in pregnancy.
citation: Lopez-Espinosa MJ, Murcia M, Iñiguez C, Vizcaino E, Costa O, Fernández-
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committees of each region approved the 
research protocol.
A tota l  of  2,644 e l ig ible  women 
(≥ 16 years, singleton pregnancy, enrollment 
at 10–13 weeks of gestation, nonassisted 
conception, delivery scheduled at the refer-
ence hospital, and no communication impair-
ment) were recruited in the first trimester of 
pregnancy and gave their written informed 
consent before inclusion (2003–2008). After 
we excluded the women who withdrew from 
the study, were lost to follow-up, or had 
induced or spontaneous abortions or fetal 
deaths, 2,506 (95%) women were followed 
up to delivery (May 2004–August 2008). In 
the present study, the sample size was 2,407 
mothers and their newborns (Table 1) with 
at least two valid ultrasounds and OC deter-
minations in maternal (n = 2,369) and/or 
cord (n = 1,140) serum. The maternal and 
newborn characteristics of this study sample 
were comparable to those of the rest of the 
cohort (data not shown).
OC exposure assessment. We measured 
OC concentrations in maternal serum 
samples of the four cohorts and in umbilical 
cord serum samples of three cohorts (Asturias, 
Gipuzkoa, and Valencia). Samples collected 
in Gipuzkoa and Sabadell were analyzed at 
the Basque Government’s Public Health 
Laboratory in San Sebastian [limit of detec-
tion (LOD) of 0.071 ng/mL for all the OCs], 
and samples from Asturias and Valencia 
were analyzed at the Barcelona Institute 
of Environmental Assessment and Water 
Research (LODs of OCs between 0.010 
and 0.035 ng/mL), as previously described 
(Goñi et al. 2007; Vizcaino et al. 2010). OC 
concentrations were determined by gas chro-
matography with electron capture detection 
and confirmation by gas chromatography 
coupled to a mass spectrometer detector. 
Both laboratories complied with the Arctic 
Monitoring and Assessment Program for 
persistent organic pollutants in human serum 
(Centre de Toxicologie, Institut National de 
Santé Publique du Québec). In this study, we 
present the results of those OCs with a detec-
tion frequency > 80% (4,4´-DDE, HCB, 
and PCBs 138, 153, and 180). Values below 
the LOD were replaced by values within the 
range [0, LOD] based on a multiple imputa-
tion procedure (see “Statistical analysis”).
We determined total cholesterol and triglyc-
erides by enzymatic techniques, and calculated 
total serum lipid concentrations (Phillips et al. 
1989). Means (± SDs) of total lipid contents in 
maternal and cord serum were 6.02 ± 1.10 and 
2.53 ± 0.67 mg/mL, respectively.
Fetal ultrasonography .  Ultrasound 
examinations were routinely scheduled for 
gestational weeks 12, 20, and 34, and were 
performed by obstetricians who specialized 
in conducting this type of examination at 
the respective hospitals. We also had access 
to the records of any other ultrasound scan 
performed on the women during pregnancy, 
which allowed us to obtain 2–8 valid ultra-
sound measurements per subject between 
the 7th and 42nd weeks of gestation. Of 
2,478 women providing ultrasound data, 
164 (6.6%) had two examinations, 2,035 
(82.1%) had three, 235 (9.5%) had four, and 
44 (1.8%) had five or more. Thus, we used 
a total of 7,602 scans to build longitudinal 
growth curves for fetal parameters (Iñiguez 
et al. 2013).
Gestational age was based on the self-
reported date of the last menstrual period, 
but it was estimated using an early crown–
rump length measurement if the self-reported 
and estimated dates differed by ≥ 7 days 
(Westerway et al. 2000). We removed women 
for whom this difference exceeded 3 weeks 
from the study to avoid possible bias (n = 18).
Fetal measures were abdominal circumfer-
ence (AC), biparietal diameter (BPD), and 
femur length (FL). We also eliminated data 
outside the range of the mean ± 4 SDs for 
each gestational age to avoid the influence of 
extreme values (n = 5, 8, and 8 for AC, FL, 
and BPD, respectively). Additionally, we calcu-
lated estimated fetal weight (EFW) using the 
Hadlock algorithm (Hadlock et al. 1985). We 
used linear mixed models (Pinheiro and Bates 
2000) separately in each cohort to obtain longi-
tudinal growth curves for the four fetal param-
eters. Our aim was to discriminate between 
small fetuses (related to the size of the general 
population) and reduced growth (related with 
the characteristics of the fetus itself) (Mamelle 
et al. 2001). Therefore, we adjusted models 
for those available covariates related to the 
constitutional potential of the fetus (Mamelle 
et al. 2001). Fetal growth modeling is briefly 
described below and in greater detail in the 
Supplemental Material, “Detailed modeling 
procedure of mixed-effect models and growth 
curves,” Table S1, and Figures S1–S4.
The full model parameterization for each 
fetal parameter in each cohort is
 Y (λ)ij = Xijβ + Zijbi + εij, [1]
where
• Y (λ)ij is a Box-Cox transformation of the fetal 
parameter value Yij in the ith fetus at time 
Tj, suggested by Gurrin et al. (2001) and 
Royston and Altman (1994), in order to 
obtain normality and linearity; 
• Xij = [1, p(Tij), C1i,…,CPi, Tij × C1i,…,Tij 
× CPi ] is the fixed-effects regressor matrix 
for the ith fetus at time Tj. p(Tij) represents 
a polynomial of entire order until 3 in Tj or 
a low-order fractional polynomial, described 
by Royston and Altman (1994). (C1i,…,CPi ) 
is the subset of the covariates considered for 
the ith fetus: maternal and paternal height, 
maternal and paternal weight or body mass 
index (BMI), maternal age, parity, country 
of origin, and fetal sex. Finally, (Tij × C1i,…, 
Tij × CPi ) represent the interactions of each 
covariate with the time at measurement; 
•	β is the vector of fixed coefficients to be 
estimated; 
• Zij = [1, Tij] is the random-effects regressor 
matrix for the ith fetus at time Tj; 
• bi is the vector of random effects that 
is estimated for each fetus, and whose 
distribution across the fetal population is 
assumed to be bivariate normal, bi = (b0i, 
b1i) ∝	N (0, D); 
•	εij is the within-subject error, εi = (εi1,…,εiN)	
∝	N	(0,	σ2Λi).
In our models the standard assumption 
of Λi = I was relaxed in order to allow for 
a) heteroscedasticity, and b) autocorrelation 
modeling of within-subject errors. This was 
performed in the following way:
	 Λi (j,j) = g(Tij, Ci, Mi, δ) [2]
	 Λi (j,k) = f(djk, ϕ), [3]
where
• g(x) is a function, assigning different 
variances to each value x, according to a 
parameter δ. Time (T), biological covariates 
(C), and a series of dichotomous variables 
(M1i,…,M
Q
i ) tagging pregnancies with at 
least two consecutive ultrasounds performed 
too close together in time were tested as 
variables explaining heteroscedasticity. Mj 
were often included in the models; 
Table  1. Study population: the INMA Project, 
2003–2008 (Spain) (n = 2,407).
Variable
Mean ± SD or 
n (%)
Maternal characteristics
Age (years) 31 ± 4.3
Height (cm) 163 ± 6.2
BMIa (kg/m2) 24 ± 4.4
Recommended GWGb 890 (38)
Born in Spain 2,209 (92)
Primary studies 588 (25)
Working in pregnancy 2,008 (83)
Lowest social class 1,045 (43)
Rural residence 141 (6)
Primiparous 1,347 (56)
Smokingc 739 (32)
Passive smoking 1,452 (62)
Alcohol intake 299 (13)
Paternal characteristics 
Height (cm) 176 ± 7.0
BMI (kg/m2) 26 ± 3.4
Child characteristics
Sex (male) 1,245 (52)
Abbreviations: BMI; body mass index; GWG; gestational 
weight gain.
aPrepregnancy BMI. bRecommended GWG during 
the 2nd and 3rd trimester according to the prepreg-
nancy BMI: 0.44–0.58, 0.35–0.50, 0.23–0.33, and 0.17–
0.27 kg/week for underweight, normal, overweight, and 
obese women, respectively (Rasmussen et al. 2009). cAt 
week 12 of pregnancy.
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• f(x) is a function modeling the auto- 
correlation structure within subjects. 
Different models of decays with distance 
were tested but in our models an exponen-
tial variogram was always selected. This 
model represents an exponential decay in 
the correlation between observations with 
the difference in time between them, that is, 
f (djk,ϕ) = 1 – exp(djk/ϕ). djk = |Tij – Tik| and 
ϕ parameter to be estimated.
The selection criterion to select the covari-
ates included in X, Z as well as explaining 
heteroscedasticity for within-subject errors, 
was p < 0.05 (conditional F-test for fixed 
effects; LR-test for random effects).
Fetal growth curves provided predictions 
for weeks 12, 20, and 34, and were used to 
calculate unconditional and conditional SD:
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Unconditional scores (Equation 4) describe 
the size of a fetus and were calculated at 12, 
20, and 34 weeks of gestation. Conditional 
SD scores (Equation 5)—that is, the standard-
ization of the response at time T2, according 
to the observed value at time T1—evaluate the 
growth in the interval T1–T2, and were calcu-
lated for the intervals 12–20 and 20–34 weeks 
of gestation.
Other covariates .  During the first 
and third trimesters of pregnancy, women 
completed two detailed in-person question-
naires on anthropometric, sociodemographic, 
and lifestyle characteristics, as well as two 
semi-quantitative food frequency question-
naires, as further described elsewhere (Llop 
et al. 2010). We considered the following 
maternal variables: age (years); height (centi-
meters); prepregnancy BMI (kilograms per 
meter squared); weekly gestational weight 
gain (GWG) from week 12 to delivery (low, 
recommended, and high) in accordance with 
the recommendations of the Institute of 
Medicine (Rasmussen et al. 2009); country 
of birth (Spain, Latin America, and other); 
area of residence (rural and urban); educa-
tion (up to primary, secondary, and univer-
sity); employment during pregnancy (yes and 
no); socioeconomic status according to the 
most privileged occupation of the mother 
or father during pregnancy [International 
Standard Classification of Occupations class 
I: managerial jobs, senior technical staff, 
and commercial managers; class II: skilled 
nonmanual workers; and class III: manual 
workers (Domingo-Salvany et al. 2000)]; 
parity (0 and ≥ 1 births); tobacco consump-
tion at week 12 of pregnancy (yes and 
no); passive smoking at home, workplace, 
or leisure areas/restaurants (yes and no); 
season of last menstrual period; and intake 
of vegetables (grams/day), fruit (grams/day), 
seafood (including three variables: lean fish, 
oily fish, and other seafood in grams/day); 
total energy (kilocalories/day); and beverages 
containing alcohol (yes and no). We also 
considered paternal height (centimeters) and 
BMI (kilograms per meter squared), and sex 
of the fetus.
Statistical analysis. For descriptive 
purposes, we present numbers and percent-
ages for categorical variables, and means and 
SDs for continuous variables. Percentiles (P) 
25, P50, and P75 are presented for OCs. We 
evaluated placental transfer by calculating 
P25, P50, and P75 of the ratios of maternal 
and umbilical cord OC concentrations, and 
Pearson partial correlations between the 
compounds (log2-transformed) adjusted by 
cohort. We also used Pearson correlations 
adjusted by cohort to describe pairwise rela-
tionships between log2(OC) measured in the 
same matrix. Contaminant concentrations 
are expressed as wet-weight concentrations 
(nanograms per milliliter) and in nanograms 
per gram lipid for descriptive analyses.
We conducted multiple linear regression 
analyses to analyze the association between 
maternal and cord serum OC concentrations 
and SD scores of fetal growth measurements 
at weeks 0–12, 12–20, 20–34, and size at 
34 weeks of gestation. We used wet-weight 
OC concentrations with adjustment for 
maternal or cord lipid levels as a separate 
term to minimize potential biases due to lipid 
standardization (Schisterman et al. 2005), 
after log2-transformation of OC [log2(OC)] 
and lipid concentrations to account for right 
skewed distributions. To identify predictor 
and confounder variables, we conducted 
linear regression analyses to determine covari-
ates associated with fetal growth outcomes 
and Tobit regression to study the relationship 
between covariates and log2(OC) concentra-
tions, accounting for the left-censoring of the 
data at the LOD (Lubin et al. 2004). The 
adjustment for covariates was performed in 
line with the following procedure. First, we 
included in basal models any variable associ-
ated with each outcome in bivariate analyses 
at a significance level of p < 0.20. Then, we 
sequentially excluded variables not related 
at p < 0.10 using the F-test and following a 
backward procedure. Later, we also added any 
potential confounder (included in the section 
of covariates) of OCs to the models if the 
OC coefficient changed by > 10% when it 
was added. Moreover, we included in all the 
models, regardless of their statistical signifi-
cance, the following variables: cohort, total 
serum lipid levels, maternal age, maternal 
BMI, and maternal country of birth, because 
these four latter were strongly associated with 
OCs in previous studies (Ibarluzea et al. 2011; 
Llop et al. 2010; Vizcaino et al. 2010). GWG 
was also included in some models (Govarts 
et al. 2014; Verner et al. 2013; Vizcaino et al. 
2014b). Specifically, GWG was included in 
models of cord OCs and outcomes measured 
from week 12 onward because GWG was 
calculated from week 12 to delivery. We 
assessed the normality and homoscedasticity of 
regression residuals, excluding extreme outliers 
(studentized residuals ≥ 4) or highly influential 
observations (Cook’s distance > 0.5) from the 
main analyses.
Final models were stratified by cohort to 
account for the possible heterogeneity of the 
association between exposure and response 
variables. Final coefficients and their 95% 
confidence intervals (CIs) were estimated using 
meta-analysis. Heterogeneity was quantified 
with the I2 statistic (Higgins et al. 2003) and 
the random-effects model was used when 
levels were > 50%. Parameter estimates were 
expressed as the percentage of change in the 
outcome with respect to the mean, and its 
95% CI associated with a doubling in the 
OC concentrations.
We used multiple imputation with 
chained equations (Sterne et al. 2009) to 
deal with missing values in covariates and 
with values < LOD in exposure variables 
[avoiding the fixed imputation of LOD/2 
by assuming a log-normal distribution of 
OCs and conditioning the imputation to 
the range (0, LOD)]. We generated a total 
of 50 complete data sets by using the mice 
package for R (van Buuren and Groothuis-
Oudshoorn 2011), and estimates on each 
data set were combined using Rubin’s rules 
for multiple imputation (Little and Rubin 
2002). To impute OC values < LOD, we 
defined an additional function for bootstrap 
multiple imputation of interval censored vari-
ables (Lubin et al. 2004). Information on the 
multiple imputation procedure is available 
in the Supplemental Material, “Details on 
multiple imputation (MI) modeling,” and 
Table S2. All results in the present work 
(including the description of OC concentra-
tions, the Pearson correlation analyses, and 
the final cohort-specific adjusted models) 
were based on pooled estimates from a 
multiple imputed data set.
We carried out different sensitivity 
analyses to evaluate the robustness of the 
results. First, we compared models using 
multiple imputation (the main analysis of 
our study) with the complete case analysis 
Lopez-Espinosa et al.
160 volume 124 | number 1 | January 2016 • Environmental Health Perspectives
(models restricted to subjects with complete 
data in covariates and replacing OC values 
< LOD with LOD/2 value). In models of 
multiple imputation, we conducted a 
multi-pollutant analysis that simultaneously 
included the OCs showing an association 
with fetal growth in the present analysis. 
We also ran an analysis excluding GWG. 
Finally, we investigated differences by sex by 
including the interaction of this variable with 
the contaminants in the main analyses.
We used the statistical software R.3.1.1 
(R Core Team 2014). Where associations 
are referred to as statistically or marginally 
significant associations, this implies a p-value 
< 0.05 or < 0.1, respectively.
Results
Study population characteristics. Table 1 
shows the characteristics of the study popula-
tion. Mean maternal age was 31 years (range, 
16–43 years); 56% of the mothers were 
primiparous, and 32% were smokers at the 
beginning of pregnancy.
OC concentrations. Wet-weight concen-
trations of OCs in maternal and cord serum 
samples are shown in Table 2. We used 
individual total lipid values to calculate 
OC concentrations on a lipid content basis. 
Maternal medians for 4,4´-DDE, HCB, as 
well as for PCBs 138, 153, and 180, were 
141, 50, 29, 48, and 34 ng/g lipid, respec-
tively. Respective cord medians were 154, 61, 
34, 48, and 34 ng/g lipid (data not shown).
Maternal and cord serum OC correla-
tions and placental transfer of contaminants. 
Three of the four participant cohorts (Asturias, 
Gipuzkoa, and Valencia) had information on 
both maternal and cord serum OC concen-
trations. Table 3 shows the Pearson correla-
tion coefficients between maternal and cord 
log2(OC) concentrations expressed in ng/mL 
as well as in ng/g lipid (range, 0.38–0.77, 
p < 0.001 in all cases). Maternal serum concen-
trations (nanograms per milliliter) of DDE, 
HCB, and PCBs 138, 153, and 180 averaged 
2.46, 2.11, 2.41, 2.55, and 2.79 times those of 
cord serum, respectively. Ratios were close to 1 
when OC concentrations were lipid-adjusted 
(Table 3). In the Supplemental Material, 
Table S3 shows the Pearson’s correlations 
between OCs in the same matrix (p < 0.001 
in all cases) being similar using the wet-
weight and the lipid-adjusted concentrations. 
Correlations were lower between DDE and 
other OCs (ranges, 0.12–0.27 and 0.31–0.39 
in maternal and cord serum, respectively), and 
higher between HCB and PCBs or between 
PCB congeners (ranges, 0.53–0.88 and 0.54–
0.82 in maternal and cord serum, respectively).
OC exposure and ultrasound measure-
ments of fetal growth. In Figure 1, the 
adjusted regression analyses are shown 
for the relationship between log2(OC) 
concentrations measured in either maternal 
or cord serum samples and SD scores of fetal 
growth or size (percent of change; 95% CI, 
for a doubling in OCs).
Between 0 and 12 weeks of pregnancy, 
there were not statistically significant asso-
ciations between OC concentrations and fetal 
outcomes except in the case of cord HCB 
(–2.3%; 95% CI: –4.4, –0.2%) or cord 
PCB-138 (–2.6%; 95% CI: –5.1, –0.1%) 
and AC growth. Marginally significant 
inverse associations (p < 0.10) were also found 
between cord HCB and EFW and between 
cord PCB-138 and the rest of fetal outcomes.
For the period between 12 and 20 weeks 
of gestation, we did not find any statisti-
cally significant associations between OC 
concentrations and growth of BPD or FL. 
Regarding AC growth, patterns were similar 
for maternal and cord serum (Figure 1), but 
only statistically significant for cord PCB-138 
(–3.3%; 95% CI: –5.8,  –0.8%) and 
PCB-180 (–3.7%; 95% CI: –6.5, –0.9%). 
Marginally significant inverse associations 
were also found between AC and the rest of 
OCs measured in cord (4,4´-DDE, HCB, 
and PCB-153). Associations for EFW growth 
did not reach statistical significance but were 
marginal with maternal PCBs 138 and 153.
For the period between 20 and 34 weeks 
of pregnancy, negative associations were 
observed for all the fetal outcomes and 
PCBs measured in either maternal or cord 
serum. These associations were significant 
for maternal PCB-138 and EFW growth 
(–2.1%; 95% CI: –4.2, –0.1%), maternal 
PCBs and FL growth (PCB-138: –2.8%; 
95% CI: –4.9, –0.8%; PCB-153: –3.8%; 
95% CI: –6.0, –1.6%; and PCB-180: –3.0%; 
95% CI: –5.3, –0.7%), and cord PCBs and 
BPD growth (PCB-138: –2.8%; 95% CI: 
–5.3, –0.3%; and PCB-153: –3.1%; 95% CI: 
–6.0, –0.2%).
Patterns of associations on growth param-
eters were coherent with those observed on 
size at 34 weeks, but only some associa-
tions were statistically significant (Figure 1). 
Negative associations between cord PCBs 138 
and 153 and growth in BPD between 20 and 
34 weeks of gestation were also apparent for 
the same exposures and BPD size at 34 weeks, 
though the association with PCB-153 was 
only marginally significant. All three PCBs 
measured in maternal serum were associated 
with significantly lower FL growth between 
20 and 34 weeks of gestation and smaller FL 
size at 34 weeks. Although AC growth was 
significantly lower in association with cord 
HCB and PCB-138 at 0–12 weeks, and with 
cord PCBs 138 and 180 at 12–20 weeks, AC 
size at week 34 was not clearly associated with 
either exposure. No significant associations 
between DDE and fetal growth were observed 
during pregnancy.
The estimates of the main analysis (i.e., 
multiple imputation) were similar to those of 
Table 2. Percentage ≥ LOD and median (P25, P75) of OCs (ng/mL): the INMA Project, 2003–2008 (Spain).
Variable 4,4´-DDE HCB PCB-138 PCB-153 PCB-180
Maternal serum 
Overall % ≥ LOD 99.2 93.2 90.9 96.2 93.6
Overall (n = 2,369) 0.83 (0.49, 1.56) 0.29 (0.16, 0.51) 0.17 (0.11, 0.25) 0.28 (0.19, 0.40) 0.20 (0.13, 0.30)
Asturias (n = 450) 1.39 (0.80, 2.41) 0.37 (0.22, 0.58) 0.20 (0.14, 0.29) 0.34 (0.24, 0.45) 0.24 (0.16, 0.34)
Gipuzkoa (n = 596) 0.54 (0.35, 0.84) 0.20 (0.12, 0.32) 0.18 (0.13, 0.26) 0.30 (0.21, 0.43) 0.22 (0.14, 0.34)
Sabadell (n = 594) 0.71 (0.43, 1.16) 0.23 (0.13, 0.38) 0.11 (0.07, 0.16) 0.20 (0.14, 0.28) 0.14 (0.09, 0.20)
Valencia (n = 729) 1.09 (0.64, 1.90) 0.43 (0.21, 0.69) 0.20 (0.13, 0.28) 0.30 (0.21, 0.41) 0.22 (0.15, 0.31)
Umbilical cord serum 
Overall % ≥ LOD 98.3 87.7 81.8 91.6 86.3
Overall (n = 1,140) 0.38 (0.23, 0.67) 0.16 (0.09, 0.27) 0.08 (< LOD, 0.12) 0.12 (0.08, 0.17) 0.08 (< LOD, 0.12)
Asturias (n = 318) 0.47 (0.25, 0.85) 0.13 (0.09, 0.22) 0.08 (0.05, 0.12) 0.13 (0.09, 0.18) 0.07 (0.04, 0.10)
Gipuzkoa (n = 324) 0.24 (0.15, 0.37) 0.11 (< LOD, 0.17) 0.08 (< LOD, 0.12) 0.12 (0.08, 0.17) 0.10 (< LOD, 0.13)
Valencia (n = 498) 0.46 (0.30, 0.78) 0.22 (0.13, 0.36) 0.09 (0.05, 0.12) 0.11 (0.08, 0.16) 0.08 (0.05, 0.11)
Abbreviations: DDE, dichlorodiphenyldichloroethylene; HCB, hexachlorobenzene; LOD, limit of detection; OC, organo-
chlorine compound; P, percentile; PCB, polychlorinated biphenyl.
Table 3. Concentration ratios and Pearson correlations of OCs in maternal and umbilical cord serum 
(n = 1,102): the INMA Project, 2003–2008 (Spain).
OC
Expressed in ng/mL Expressed in ng/g lipid
Ratioa: Cm/Cuc  
[median (P25, P75)]
Pearsonb 
coef
Ratioa: Cm/Cuc  
[median (P25, P75)]
Pearsonb 
coef
4,4´-DDE 2.46 (1.88, 3.21) 0.77 1.04 (0.76, 1.46) 0.75
HCB 2.11 (1.49, 2.94) 0.57 0.89 (0.56, 1.36) 0.54
PCB-138 2.41 (1.69, 3.28) 0.41 1.01 (0.67, 1.47) 0.38
PCB-153 2.55 (1.93, 3.45) 0.49 1.11 (0.79, 1.52) 0.47
PCB-180 2.79 (1.96, 4.07) 0.56 1.19 (0.79, 1.79) 0.55
Abbreviations: coef, coefficient; DDE, dichlorodiphenyldichloroethylene; HCB, hexachlorobenzene; OC, organochlorine 
compound; P, percentile; PCB, polychlorinated biphenyl. Both maternal and cord concentrations were available for 
three out of the four cohorts (Asturias, Gipuzkoa, and Valencia).
aRatio: Cm/Cuc: ratio of maternal/cord concentrations in raw scale. bPearson correlation coefficient between maternal 
and cord OC concentrations in log scale (adjusted by cohort). p < 0.001 in all the Pearson correlations. 
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the complete case analysis (i.e., restricted to 
data with no missing information in covari-
ates and OC values < LOD replaced with 
LOD/2 value), the multi-pollutant analysis 
(i.e., main analysis including other OCs), or 
the main analysis excluding GWG (Figure 2; 
see also Supplemental Material, Figures S5–
S7). The main differences were found in the 
multi-pollutant analysis with wider CIs. There 
were no consistent interactions with sex (data 
not shown), and only two interactions were 
statistically significant: cord HCB and FL 
growth between 12 and 20 weeks of preg-
nancy (females: –1.9%; 95% CI: –4.9, 1.0%, 
and males: 2.3%; 95% CI: –0.4, 5.0%, 
p-interaction = 0.03) and maternal 4,4´-DDE 
and AC growth between 20 and 34 weeks 
of gestation (females: 1.5%; 95% CI: 
–0.6, 3.5%, and males: –1.2%; 95% CI: 
–2.9, 0.6%, p-interaction = 0.05).
Discussion
To the best of our knowledge, this is the first 
study to consider specific fetal body segments 
that could be affected by exposure to OCs 
during different critical exposure windows. 
Increases in PCB concentrations were related 
to reductions in AC up to mid-pregnancy, 
and to decreases in fetal BPD and FL from 
gestational week 20 onward. We also found 
an inverse association between HCB and 
AC during the first trimester of pregnancy. 
The estimated mean difference in these fetal 
parameters ranged from –4% to –2% for 
a doubling in the OC concentrations. The 
magnitudes of the estimates in the multiple 
imputation analysis were similar to those of 
the complete case analysis, as well as those of 
the multiple imputation analysis after adding 
other OCs or excluding GWG. Clear results 
suggesting a differential effect between sexes 
were not found.
No associations between serum DDE 
concentrations and ultrasound measurements 
were found. No previous studies using fetal 
anthropometry measures are available for 
comparison with our results, but controversy 
exists about birth size. Although associa-
tions were reported in some studies (Lopez-
Espinosa et al. 2011; Wolff et al. 2007), 
others found little or no evidence of asso-
ciations with DDE exposure (Govarts et al. 
2012; Sagiv et al. 2007).
Cord serum HCB concentrations were 
inversely associated with AC in early preg-
nancy. Although this fetal measure and 
birth weight are not directly comparable, 
a marginally significant decrease in birth 
weight associated to cord HCB concentra-
tions was reported in newborns from the 
INMA-Valencia cohort (Lopez-Espinosa 
et al. 2011). Additionally, a non-statistically 
significant inverse association between birth 
weight and maternal HCB concentrations 
was reported in another previous INMA 
study (Basterrechea et al. 2014).
Some PCBs measured in cord serum 
were negatively associated with AC. 
Specifically, this was the case with PCB-138 
up to the second trimester and PCB-180 
at 12–20 weeks of pregnancy. Despite the 
limitations of comparability between fetal 
and birth outcomes, a systematic analysis 
of 20 epidemiological studies on PCBs 
reported insufficient evidence of an associa-
tion with birth weight < 2,500 g (El Majidi 
et al. 2012). Conversely, an inverse linear 
exposure–response relationship between birth 
weight and cord PCB-153 was reported in 
a meta-analysis conducted in 12 European 
cohorts, which include the children in the 
present study (Casas et al. 2015; Govarts et al. 
2012). In a second analysis controlling for 
GWG, the strength of the association was 
reduced, although a statistically significant 
reduction in birth weight was still observed 
(Govarts et al. 2014). In the present study, 
maternal serum PCB-138, -153, and -180 
concentrations were associated with lower 
FL growth from 20 to 34 weeks and smaller 
FL size at 34 weeks. Cord serum PCB-138 
and -153 concentrations were associated with 
lower BPD growth from 20 to 34 weeks and 
smaller BPD size at 34 weeks (with the latter 
significant only for PCB-138). A margin-
ally significant reduction in birth length 
Figure 1. Associations between OC concentrations and fetal growth measurements: The INMA Project, 2003–2008 (Spain). Abbreviations: AC, abdominal 
circumference; BPD, biparietal diameter; DDE, dichlorodiphenyldichloroethylene; EFW, estimated fetal weight; FL, femur length; HCB, hexachlorobenzene; OC, 
organochlorine compound; PCB, polychlorinated biphenyl. Adjusted linear regression models between log2(OC) concentrations and fetal growth measurements. 
Meta-analysis of results from multiple imputation. Results expressed as percent change in fetal measurements associated with a doubling in OC concentrations. 
*p < 0.05. **p < 0.01.
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associated with cord PCB-153 concentrations 
was previously found in the INMA-Valencia 
cohort (Lopez-Espinosa et al.  2011). 
Conversely, associations with birth length or 
head circumference were not found in other 
studies (Sagiv et al. 2007; Wolff et al. 2007).
Although the biological mechanisms under-
lying the effects of OCs on fetal growth are not 
well established, these compounds can disrupt 
the endocrine system, which is involved in fetal 
development (Bourguignon and Parent 2010). 
Thus, thyroid hormones play an important role 
in somatic growth and in the differentiation 
and functioning of many tissues during devel-
opment (Blazer et al. 2003), and some studies 
have suggested the existence of an association 
between altered thyroid levels during pregnancy 
and exposure to some OCs (Alvarez-Pedrerol 
et al. 2009; Lopez-Espinosa et al. 2009). OCs 
may also impede placental functions and 
contribute to fetal growth impairment. Thus, 
exposure to some OCs has been associated with 
placental vascular and trophoblastic lesions 
in animals studies (Bäcklin et al. 1998) and 
alterations of the placental transport of calcium 
and other nutrients in humans (Hamel et al. 
2003; Tsuji et al. 2013) that are essential for 
fetal development.
Several shortcomings of the present 
study warrant cautious interpretation of the 
findings until more studies are available. 
Because multiple estimates were derived, 
results should be taken with caution: Some 
statistically significant associations could result 
from chance. The estimates of the coefficients 
and their confidence intervals should be taken 
as a global picture of the pattern of the rela-
tions between the variables involved in the 
study (Rothman 1990). Second, the criteria 
of inclusion may have imposed some selec-
tion and an underrepresentation of pregnant 
women with increased risk of adverse preg-
nancy outcomes. However, the aim of these 
commonly used criteria is to obtain a more 
homogeneous population and reduce the 
confounding potential. Another weakness is 
the possible selection bias between women 
included in or excluded from the present 
study, yet the differences in the main study 
variables observed between both groups were 
not significant. Although the OC concentra-
tions were measured in two different laborato-
ries with different LODs, both participated in 
the same monitoring and assessment program 
for persistent organic pollutants in human 
serum to verify their analytical results and 
to ensure the comparability of their data. In 
addition, random-effects meta-analysis was 
used to address heterogeneity resulting from 
the use of different laboratories and other 
factors that could differ among the cohorts.
One of the major strengths of this work 
with respect to previous studies on birth 
size is the repeated measurements of fetal 
anthropometry, which allowed us to study 
associations between OCs and growth in 
different stages of pregnancy. We accurately 
assessed fetal growth by means of a longi-
tudinal analysis, adjusting for parental and 
fetal characteristics, to compare the expected 
versus real growth of each fetus. The use of 
individualized standards is expected to reduce 
misclassification by identifying constitution-
ally small babies and those with restricted 
growth (Gardosi 2004). Second, the use of 
repeated measurements of fetal anthropom-
etry allowed us to study associations between 
these growth parameters and OCs in different 
stages of pregnancy, and thereby identify 
critical periods within gestation. Third, unlike 
most previous studies that have relied on a 
single blood measurement of exposure, we 
had information on OC exposure at the 
beginning of pregnancy and at delivery. 
Finally, other strengths of the present study 
are the large sample size, its prospective 
Figure 2. Sensitivity analysis of the association between OC concentrations and fetal size at 34 weeks 
of gestation: the INMA Project, 2003–2008 (Spain). Abbreviations: AC, abdominal circumference; BPD, 
biparietal diameter; DDE, dichlorodiphenyldichloroethylene; EFW, estimated fetal weight; FL, femur length; 
GWG, gestational weight gain; HCB, hexachlorobenzene; OC, organochlorine compound; PCB, polychlo-
rinated biphenyl. Adjusted linear regression models between log2(OC) concentrations and fetal growth 
measurements. Meta-analysis of results from multiple imputation. Results expressed as percent change in 
fetal measurements associated with a doubling in OC concentrations. Main analysis: results from multiple 
imputation. Complete case: analysis excluding cases with missing values in covariates and fixed imputa-
tion of LOD/2 for OC values < LOD. Multi-pollutant: main analysis including the OCs showing an association 
with fetal growth in the present analysis, i.e., models of 4,4´-DDE were additionally adjusted for ∑PCBs 
and HCB, models of HCB were adjusted for ∑PCBs, and models of PCBs were adjusted for HCB. Excluding 
GWG: analysis excluding gestational weight gain. 
aGWG was not included in models of maternal OCs and outcomes measured at week 12 because GWG was calculated 
from week 12 to delivery.
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design, the low rate of participant dropout 
between recruitment and delivery, detailed 
information on many potential confounders 
from early pregnancy, and the use of multiple 
imputation to deal with undetected values in 
the exposure variables and missing values in 
the covariates (Sterne et al. 2009).
Conclusions
PCB exposure may decrease fetal AC growth 
during the first two trimesters of pregnancy, 
and fetal growth of BPD and FL from mid-
pregnancy onward. A transient association 
between HCB and AC in early pregnancy was 
also found. The reduction of these parameters 
ranged from –4% to –2% for a doubling in 
the OC levels. No statistically significant asso-
ciation between DDE and fetal growth was 
observed. Ultrasound measurements consti-
tute a promising tool to examine how early 
prenatal OC exposure may affect fetal growth 
and more studies are needed.
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